Disease-causing BRCA1 and BRCA2 germline mutations overall prevalence was 0.23% in the common population, 2.8% in the BC cases before diagnostic age 70 and 6.1% in the patients before diagnostic age 50 [4]. Here, BRCA2 is linked to breast cancer.